A female infant is born prematurely at 28 weeks of gestation and has chronic lung disease of prematurity. As the winter months approach, the pediatrician discusses strategies to prevent severe respiratory syncytial virus (RSV) infection during her first year of life. Which of the following is the recommended agent for passive immunoprophylaxis?